mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34952008.
- Also identified by DOI 10.1016/j.jpeds.2021.12.025 and PMC identifier 8691954.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
Medical subject headings
- COVID-19
- Myocarditis